TMO Stock Analysis: Buy, Sell, or Hold?
TMO - Thermo Fisher Scientific, Inc.
$629.27
1.72 (0.27%)
▲
5d:
+6.97%
30d:
+9.95%
90d:
+40.03%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Oct 21, 2026
Get Alerted When TMO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: TMO shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: TMO shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$758.27
Based on 6.8% avg growth
INTRINSIC VALUE TODAY
$470.83
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 19.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TMO is currently trading at $629.27, which is considered extended relative to its 30-day fair value range of $542.89 to $602.52. From a valuation perspective, the stock is trading at a premium (Forward PE: 22.9) compared to its historical average (19.9). At these levels, the market is pricing in 4.8% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, TMO is in a strong uptrend. The price is approaching resistance at $634.70. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: TMO scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TMO is in a strong uptrend. The price is approaching resistance at $634.70. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: TMO scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$542.89 -
$602.52
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
24.8%
Protect Your Profits
TMO is technically overbought (RSI 75). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($631.42)
- NEUTRAL: Market pricing in 4.8% annual earnings growth - fairly valued
- WARNING: Composite score 41/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$542.89 -
$602.52
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$580.00
Resistance Level
$634.70
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
22.87
Wall Street Target
$631.42
(+0.3%)
Revenue Growth (YoY)
10.5%
Earnings Growth (YoY)
9.4%
Profit Margin
15.0%
Valuation Premium vs History
+4.8% premium
PE vs Historical
22.9 vs 19.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.8%
(market-implied from PE analysis)
1-Year Target
$659.47
(+5%)
2-Year Target
$691.13
(+10%)
3-Year Target
$724.30
(+15%)
3-Yr Target (if PE normalizes)
(PE: 23→20)
PE COMPRESSION
$630.13
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.9, Growth: 9.5%)
$826.73
(+31%)
Base:
(SPY PE: 20.1, Growth: 9.5%)
$725.38
(+15%)
Bear:
(PE: 17.1, Growth: 9.5%)
$616.57
(-2%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (33x PE), but valuation improves significantly next year (23x PE) as earnings recover.
Trailing PE: 33.01 | Current EPS (TTM): $19.01
Bull Case
$998.97
(+59%)
Analyst growth 44.7%, PE expands to 36.3
Base Case
$908.15
(+44%)
Market implied 44.7%, PE stable at 33.0
Bear Case
$426.73
(-32%)
Severe decline -20.0%, PE contracts to 28.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 24, 2026 12:21 AM ET
Data refreshes hourly during market hours. Next update: 1:21 AM
Data refreshes hourly during market hours. Next update: 1:21 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TMO showing a specific setup today?
Insider Activity (6 Months)
1
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-03-10
Ro Khanna
BUY
2026-03-06
Marc N Casper
SELL
5000 shares
2026-03-04
Featured in Portfolios
TMO is a key holding in these high-performance investment strategies.
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$194 | 50 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$228 | 43 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$337 | 38 SELL |
|
LH
Laboratory Corporation o… |
STRONG BUY
20 analysts |
$338 | 49 HOLD |
Advanced TMO Option Strategies
Professional options setups generated by AI based on today's TMO price and gamma walls.
